StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39−0.03 (-0.39%)

Close on Nov 17, 2026Market cap $241.88MP/E –Yield –

Lifecore Biomedical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Lifecore Biomedical's operating cash flow for the twelve months ending May 25, 2025 was -$206.00K, down 180.2% year over year. For fiscal 2025 it was -$206.00K, down 180.2% from the year before. The highest annual figure on record is $29.84M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025May 25, 2025-$206.00K-180.2%
FY2024May 26, 2024$257.00K–
FY2023May 28, 2023-$17.44M–
FY2022May 29, 2022-$22.59M-237.2%
FY2021May 30, 2021$16.47M–
FY2020May 31, 2020-$17.04M-206.4%
FY2019May 26, 2019$16.02M-19.0%
FY2018May 27, 2018$19.78M-33.7%
FY2017May 28, 2017$29.84M+43.7%
FY2016May 29, 2016$20.76M-22.0%
FY2015May 31, 2015$26.62M+26.5%
FY2014May 25, 2014$21.05M-0.9%
FY2013May 26, 2013$21.23M-4.3%
FY2012May 27, 2012$22.18M+53.3%
FY2011May 29, 2011$14.47M+93.4%
FY2010May 30, 2010$7.48M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ2 2025May 25, 2025$5.35M-38.7%
Q3 FY2025CQ1 2025Feb 23, 2025$1.20M–
Q2 FY2025CQ4 2024Nov 24, 2024-$6.14M-576.7%
Q1 FY2025CQ3 2024Aug 25, 2024-$613.00K–
Q4 FY2024CQ2 2024May 26, 2024$8.72M–
Q3 FY2024CQ1 2024Feb 25, 2024-$1.42M–
Q2 FY2024CQ4 2023Nov 26, 2023$1.29M–
Q1 FY2024CQ3 2023Aug 27, 2023-$8.33M–
Q4 FY2023CQ2 2023May 28, 2023-$2.26M–
Q3 FY2023CQ1 2023Feb 26, 2023-$11.73M–
Q2 FY2023CQ4 2022Nov 27, 2022-$2.35M–
Q1 FY2023CQ3 2022Aug 28, 2022-$1.10M-179.8%
Q4 FY2022CQ2 2022May 29, 2022-$1.85M-136.4%
Q3 FY2022CQ1 2022Feb 27, 2022-$17.31M–
Q2 FY2022CQ4 2021Nov 28, 2021-$4.81M-491.1%
Q1 FY2022CQ3 2021Aug 29, 2021$1.38M-92.0%
Q4 FY2021CQ2 2021May 30, 2021$5.09M–
Q3 FY2021CQ1 2021Feb 28, 2021-$7.07M-166.8%
Q2 FY2021CQ4 2020Nov 29, 2020$1.23M–
Q1 FY2021CQ3 2020Aug 30, 2020$17.23M–
Q4 FY2020CQ2 2020May 31, 2020-$12.70M–
Q3 FY2020CQ1 2020Feb 23, 2020$10.58M-16.3%
Q2 FY2020CQ4 2019Nov 24, 2019-$9.48M-462.4%
Q1 FY2020CQ3 2019Aug 25, 2019-$5.44M-348.8%
Q4 FY2019CQ2 2019May 26, 2019-$1.43M–
Q3 FY2019CQ1 2019Feb 24, 2019$12.65M-37.7%
Q2 FY2019CQ4 2018Nov 25, 2018$2.62M-58.7%
Q1 FY2019CQ3 2018Aug 26, 2018$2.19M-36.6%
Q4 FY2018CQ2 2018May 27, 2018-$521.00K-107.8%
Q3 FY2018CQ1 2018Feb 25, 2018$20.30M-23.8%
Q2 FY2018CQ4 2017Nov 26, 2017$6.34M-34.8%
Q1 FY2018CQ3 2017Aug 27, 2017$3.45M-65.4%
Q4 FY2017CQ2 2017May 28, 2017$6.66M-53.6%
Q3 FY2017CQ1 2017Feb 26, 2017$26.63M+541.9%
Q2 FY2017CQ4 2016Nov 27, 2016$9.71M–
Q1 FY2017CQ3 2016Aug 28, 2016$9.97M–
Q4 FY2016CQ2 2016May 29, 2016$14.33M–
Q3 FY2016CQ1 2016Feb 28, 2016$4.15M–

More Lifecore Biomedical figures

See a number that looks wrong?